There is also a need to compare the magnitude of the effect and cost effectiveness for the use of other chemicals for IRS and insecticide-treated bed nets in Ethiopia.
Diseases such as congenital adrenal hyperplasia, which is treated with glucocorticoids, might be somewhere between hypothyroidism and lysosomal storage diseases in terms of cost-effectiveness for use in LMICs.
Indeed, a UK-based study investigating the cost effectiveness of using ABPM for diagnosis concluded that the additional cost of implementing ABPM outweighed the savings made by providing more accurate diagnosis and treatment [ 12].
The high velocity oxy-fuel (HVOF) process is widely adopted by many industries due to its flexibility, cost effectiveness, handiness for use and the superior quality of the coatings produced.
The cost-effectiveness of using robots for upper limb rehabilitation, for example, has been reported in a single randomised controlled trial that also demonstrated modest clinical benefits compared with usual care at 36 weeks [ 37], but further empirical research using economic analysis is required to demonstrate consistent results.
We propose that knowledge of the pectin structures that affect recalcitrance and the means to degrade the structure(s) offer a way to improve biomass deconstruction and to provide technology to increase the cost-effectiveness of using biomass for fuels and biomaterials production.
Validation of the assay in real-world clinical practice is warranted to verify the retrospective analyses of this assay in clinical trials and ensure its cost-effectiveness for routine use in this population.
In summary, we demonstrated that the cost-effectiveness of using MUGA scans for monitoring anthracycline-induced cardiotoxicity depends on patient age and cumulative drug dose.
In the analysis, we will assess the cost-effectiveness of using an ORT for dose adjustments in poor responders ór hyperresponders only and using an ORT for dose adjustment in both poor responders and hyperresponders, as compared to current practice where no ORT is used and standard FSH doses are given.
This study would appear to be the first analysis to assess the cost-effectiveness of using alternative dietetic formulae for managing cow's milk allergic infants in Spain.
The net present value was calculated on the basis of a willingness to pay threshold of £30 000 per QALY gained, based on the perception that this is approximately the cost effectiveness threshold used for evaluating health technologies in the UK.
